InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Colleran David, Directeur Exécutif, Conseiller Juridique Général. Officer active across 2 companies, notably Anika Therapeutics, Inc.. Aggregated, 15 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €67k. Activity tracked since 4 March 2022. The latest transaction was disclosed on 17 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 条申报中的 15 条
Colleran David is Directeur Exécutif, Conseiller Juridique Général. He has 15 filings in total, and across the 15 recent filings tracked, buys total 67062 EUR and sells total 0 EUR, with activity observed between 2022-03-07 and 2026-03-17. He is linked to Anika Therapeutics, Inc., where his listed function is EVP, General Counsel, Corp Sec.